Back
Milestone Pharmaceuticals Vs. NovoCure Industry Stock Comparison
Sell
47
MIST
Milestone Pharmaceuticals
Last Price:
$1.96
Seasonality Move:
-21.27%
Sell
35
NVCR
NovoCure
Last Price:
$26.23
Seasonality Move:
-0.94%
Sell
47
Milestone Pharmaceuticals (MIST)
is a Sell
Is Milestone Pharmaceuticals a Buy, Sell or Hold?
-
The current Milestone Pharmaceuticals [MIST] share price is $1.97. The Score for MIST is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MIST Stock Price Chart
What is Milestone Pharmaceuticals's stock price today?
-
The Milestone Pharmaceuticals share price today is $1.97The current trend is moderately bearish and MIST is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
MIST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 48.34 | Sell |
Chaikin Money Flow: | -484705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.78 - 2.16) | Sell |
Bollinger Bands (100): | (1.43 - 1.93) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.81 | Buy |
Relative Strength Index (14 RSI): | 46.03 | Sell |
Chaikin Money Flow: | 204115 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.45 - 31.61) | Sell |
Bollinger Bands (100): | (14.63 - 26.63) | Buy |
MIST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.17 | Sell |
20-day SMA: | 2 | Sell |
50-day SMA: | 1.88 | Buy |
200-day SMA: | 1.61 | Buy |
8-day EMA: | 2.11 | Sell |
20-day EMA: | 2.04 | Sell |
50-day EMA: | 1.89 | Buy |
200-day EMA: | 1.8 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.05 | Sell |
20-day SMA: | 30.33 | Sell |
50-day SMA: | 24.44 | Buy |
200-day SMA: | 19.26 | Buy |
8-day EMA: | 28.8 | Sell |
20-day EMA: | 28.88 | Sell |
50-day EMA: | 25.77 | Buy |
200-day EMA: | 21.57 | Buy |
Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.95 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
Milestone Pharmaceuticals Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |